Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Cancer

INDICATION: Renal cancer

In vitro and cell culture studies identified an aminothiazole-based negative allosteric modulator (NAM)

Read the full 158 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE